Canaccord Genuity Maintains a 'Buy' on Anacor Pharmaceuticals (ANAC); Derm Pipeline Priority Shift
Tweet
Share
E-mailGet Alerts ANAC Hot Sheet
Price: $10.19 --0%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Anacor Pharmaceuticals (NASDAQ: ANAC) price target of $11.00.
Analyst, George Farmer, said, "We see an attractive entry point following share pullback and recent financing. Revised direction for topical PDE4 inhibitor AN2728 as treatment for atopic dermatitis (AD) provides meaningful upside potential, in our view...In our view, positive results from two Phase II bridging studies evaluating topical AN2728 administration further support a clean safety and tolerability profile. Shifting ANAC priorities and putting AD as the lead indication for this drug makes sense to us given the high medical need."
For an analyst ratings summary and ratings history on Anacor Pharmaceuticals click here. For more ratings news on Anacor Pharmaceuticals click here.
Shares of Anacor Pharmaceuticals closed at $6.04 yesterday.
Analyst, George Farmer, said, "We see an attractive entry point following share pullback and recent financing. Revised direction for topical PDE4 inhibitor AN2728 as treatment for atopic dermatitis (AD) provides meaningful upside potential, in our view...In our view, positive results from two Phase II bridging studies evaluating topical AN2728 administration further support a clean safety and tolerability profile. Shifting ANAC priorities and putting AD as the lead indication for this drug makes sense to us given the high medical need."
For an analyst ratings summary and ratings history on Anacor Pharmaceuticals click here. For more ratings news on Anacor Pharmaceuticals click here.
Shares of Anacor Pharmaceuticals closed at $6.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
- BJ's Wholesale (BJ) PT Raised to $115 at UBS as Business Model 'Remains Relevant'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
